Blinatumomab 38.5micrograms powder and solution for solution for infusion vials
in short Blinatumomab 38.5micrograms inf vials
previously Blinatumomab 38.5micrograms powder for solution for infusion vials
- SNOMED code
31143811000001101- Named
- Active compound
- Blinatumomab
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Blinatumomab
— 38.5 microgram
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder and solution for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials (Amgen Ltd)
in short Blincyto 38.5micrograms inf vials
previously Blincyto 38.5micrograms powder and solvent for solution for infusion vials
Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials
- SNOMED code
31143911000001106- Named
- Supplier
- Amgen Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials (Amgen Ltd) 1 vial31144111000001105 ref. pack | 💯 Available Legal category: POM | 8715131009922End: 087151310237068715131023706End: | NHS Indicative Price £2,017 | • Hospital |
| — |
Reference packs
Blinatumomab 38.5micrograms powder and solution for solution for infusion vials 1 vial
- SNOMED code
31144011000001109- Quantity and unit
- 1 vial
- Packs